Implementation of Screening Programs for Diagnosis of Sexually Transmitted Diseases to Promote Uptake of Diagnostic Testing

According to the World Health Organization (WHO), more than 1 mn sexually transmitted infections (STIs) are acquired every day across the globe. Most of them go untreated as a result of lack of diagnosis. Undiagnosed STDs can have critical consequences on maternal, reproductive and newborn health. A large diseased population can challenge the socioeconomic development of a country. Therefore, governments of various countries are encouraging the use of diagnostic testing of STDs to spread awareness amongst the common mass. This is the key factor driving the global diagnostic testing of STDs market. 

Get Free Sample Research Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1631

According to a study by Transparency Market Research (TMR), the global diagnostic testing of STDs market was valued at US$65.9 bn in 2012 and is anticipated to reach US$108.5 bn by the end of 2019 at a CAGR of 8.10% between 2013 and 2019.

Why are governments taking a keen interest in promoting the growth of the diagnostic testing of STDs market?

Given the huge public health burden that STDs can have, governments across the world have implemented national screening programs that deploy various equipment and machines for the diagnosis of STDs. These programs have encouraged people to undergo diagnosis tests at more affordable costs, thereby increasing the popularity of diagnostic testing of STDs. This has, in turn, boosted the growth of the global diagnostic testing of STDs market.

Another factor that is driving the growth of the global diagnostic testing of STDs is the favorable reimbursement offered by insurers for STDs testing. The coverage provided by health insurance has stimulated the interest of people in undergoing diagnosis test.

Is social stigma besetting the growth of the global diagnostic testing of STDs market?

Those afflicted with STDs commonly tend to shy away from proper testing facilities due to the social stigma associated with the diseases. As a result, a lot less patients actually get diagnosed with STDs in comparison to the number of patients possibly affected by them. This factor is likely to deter the growth of the global diagnostic testing of STDs market.

Other than this, the screening centers are often operated in urban or semi urban areas. This makes these centers out of reach for a large number of STD infected patients who are living in remote locations or rural areas. This, therefore, restrains the growth of the global diagnostic testing of STDs market.

How lucrative is the global diagnostic testing of STDs market for new entrants?

A growing prevalence of STDs has propelled the demand for efficient diagnostics testing of STDs. The presence of large pool of patients along with immense untapped opportunities in regions such as Asia Pacific and MEA is attracting many vendors to cater the market for diagnostic testing of STDs. Moreover, rising awareness for STD diagnosis in developed nations of North America and Europe is fuelling the growth of the global diagnostic testing of STDs market.

However, the stringent regulatory compliance requirements associated with diagnostic testing of STDs are limiting the entry of new vendors. Furthermore, the high investment of capital of research hampers the entry of new players in the global diagnostic testing of STDs market.

Browse Research Report on Global Diagnostic Testing of STDs Market:
http://www.transparencymarketresearch.com/diagnostic-testing-stds.html

Diagnostic Testing of STDs Market is Expected to Reach USD 108.5 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research “Diagnostic Testing of STDs Market (Laboratory Testing, Point-Of-Care Testing, Laboratory Equipment and Supplies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global Diagnostic Testing of STDs market was valued at USD 65.9 billion in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an estimated value of USD 108.5 billion in 2019.

Browse the full Diagnostic Testing of STDs Market Report at http://www.transparencymarketresearch.com/diagnostic-testing-stds.html

Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual contacts. STDs result in high morbidity in adults and also result in complications such as infertility in both men and women, ectopic pregnancy, cervical cancer in women and congenital mortality and other infections and complications. STDs are a health issue that majorly affect populace aged 15 - 44 years and results in ~500 million new infections or cases per year globally. Undiagnosed (that often results in untreated cases) STDs can have critical implications for reproductive, maternal and newborn health. WHO has highlighted the need and prioritizing control of STDs. In May 2006, the World Health Assembly endorsed a global strategy for the prevention and control of STDs and identified action-points of scale-up of effective services of STDs case management and counseling via: Screening and Diagnostic Testing and Treatment. Timely diagnosis of STDs is thus imperative for prevention of transmission, control and reducing the risk of incurable and fatal STD infections.

STDs are caused by bacteria, viruses and parasites. Some of the most prevalent STDs that are studied are: Chlamydia, Gonorrhea, P&S Syphilis, Chancroid, AIDS (causative agent - HIV), Genital Herpes (causative agent - Herpes Simplex Virus (HSV)), Genital Warts, Cervical Cancer, Anal Cancer, Vulval/Vaginal Cancer, Penal Cancer, (few types) of Oral and Throat Cancers (causative agent - Human Papilloma Virus (HPV)). The market size of diagnostic testing of above-mentioned STDs thus refers to the testing volume by each STD type and the value of the testing services rendered in USD million.

Globally, the HPV testing is a high growth market segment that is expected to grow at very high CAGR of over 70% during the forecast period till 2019. HPV is of two types - Low-risk HPV manifest as warts and High-risk HPV that cause varied forms of cancer. The prevalence and incidence rates and number of cases for Low-risk HPV infections depends on the first presentation of warts by the patients and Low-risk HPV diagnostic tests cannot be of ‘screening’ nature. For High-risk HPV types, HPV ‘co-testing’ is done by varied laboratory testing methods and additionally, pap smear tests are also carried out to detect High-risk HPV types in cancer cases. Thus the HPV testing volume is a cumulative result of factors and thus due to these reasons, we estimate that HPV testing volume is expected to grow at a very high CAGR till 2019.

Currently, in terms of geography, North America and Europe have a higher market share in terms of testing volume of the most prevalent STDs namely Chlamydia, Gonorrhea and P&S Syphilis. Many countries in Asia-Pacific and the entire RoW region has garnered a higher market share in terms of testing volume of primarily viral STDs such as HIV, HSV and Chancroid.

The Global Diagnostic Testing of STDs market is segmented as follows:

Diagnostic Testing of STDs Market, by STD type

·        Chlamydia testing

·        Gonorrhea testing

·        P&S Syphilis testing

·        Human Papilloma Virus (HPV) testing

·        Herpes Simplex Virus (HSV) testing

·        Human Immunodeficiency Virus (HIV) testing

·        Chancroid testing

Diagnostic Testing of STDs Market, by Location

·        Laboratory Testing

·        Point-Of-Care (POC) Testing

Diagnostic Testing of STDs Market, by Geography

·        North America

·        Europe

·        Asia-Pacific

·        Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse the full Diagnostic Testing of STDs Market Report at http://www.transparencymarketresearch.com/diagnostic-testing-stds.html